Michaela Kuhn
Wuerzburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
Atrial natriuretic peptide counteracts aldosterone secretion by preventing acute angiotensin II-induced cAMP signalling.
Journal: British journal of pharmacology
Published: October 27, 2025
Interferon gamma signaling drives cardiac metabolic rewiring.
Journal: bioRxiv : the preprint server for biology
Published: September 15, 2025
C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension.
Journal: Communications biology
Published: December 16, 2024
Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity.
Journal: Science advances
Published: October 09, 2024
Auto/Paracrine C-Type Natriuretic Peptide/Cyclic GMP Signaling Prevents Endothelial Dysfunction.
Journal: International journal of molecular sciences
Published: May 20, 2024
Keeps Cardiac Pericytes in Good Shape: Regulator of G-Protein Signaling-5.
Journal: Circulation research
Published: May 09, 2024
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors.
Journal: British journal of pharmacology
Published: December 20, 2023
C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension.
Journal: Communications biology
Published: July 27, 2023
Natriuretic peptide pathways in heart failure: further therapeutic possibilities.
Journal: Cardiovascular research
Published: May 16, 2022
Last Updated: 09/26/2026